Literature DB >> 8385842

Baculovirus-expressed herpes simplex virus type 2 glycoprotein D is immunogenic and protective against lethal HSV challenge.

V Landolfi1, C D Zarley, A S Abramovitz, N Figueroa, S L Wu, M Blasiak, S T Ishizaka, E M Mishkin.   

Abstract

Herpes simplex virus type 2 glycoprotein D (gD2) was cloned and expressed in the baculovirus-Spodoptera frugiperda system. Milligram quantities of glycoprotein were recovered from suspension culture and subjected to purification by ion-exchange and immunoaffinity chromatography. The resultant purified gD existed as a homogeneous 57,500 MW monomeric species demonstrating reactivity with anti-gD monoclonal antibodies including those directed at a non-sequential neutralizing epitope of gD. Immunization of Balb/c mice with doses of 0.1-10.0 micrograms of AlPO4-absorbed gD resulted in elicitation of humoral and cellular responses to both HSV1 and HSV2 as well as to purified gD1 and gD2. Immunized mice receiving an infectious dose of 1 x 10(6) p.f.u. of HSV2 via the footpad route were significantly protected against infection at all doses tested when compared with unimmunized AlPO4 and uninoculated control animals.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8385842     DOI: 10.1016/0264-410x(93)90280-b

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Immunization with combined HSV-2 glycoproteins B2 : D2 gene DNAs: protection against lethal intravaginal challenges in mice.

Authors:  Hyung Hoan Lee; Soung Chul Cha; Dong June Jang; Jun Keun Lee; Dong Wan Choo; Young Sik Kim; Hong Sun Uh; Soo Young Kim
Journal:  Virus Genes       Date:  2002-10       Impact factor: 2.332

2.  Downstream processing of insect cell cultures.

Authors:  A R Bernard; M Lusti-Narasimhan; K M Radford; R S Hale; E Sebille; P Graber
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

3.  High-level expression and purification of secreted forms of herpes simplex virus type 1 glycoprotein gD synthesized by baculovirus-infected insect cells.

Authors:  W P Sisk; J D Bradley; R J Leipold; A M Stoltzfus; M Ponce de Leon; M Hilf; C Peng; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

4.  Liposomal gD ectodomain (gD1-306) vaccine protects against HSV2 genital or rectal infection of female and male mice.

Authors:  K Olson; P Macias; S Hutton; W A Ernst; G Fujii; J P Adler-Moore
Journal:  Vaccine       Date:  2009-10-14       Impact factor: 3.641

5.  Phase I study of a herpes simplex virus type 2 (HSV-2) DNA vaccine administered to healthy, HSV-2-seronegative adults by a needle-free injection system.

Authors:  Ashok Cattamanchi; Christine M Posavad; Anna Wald; Yaela Baine; Jennifer Moses; Terry J Higgins; Richard Ginsberg; Richard Ciccarelli; Lawrence Corey; David M Koelle
Journal:  Clin Vaccine Immunol       Date:  2008-09-10

6.  Characterization of recombinant polioviruses expressing regions of rotavirus VP4, hepatitis B surface antigen, and herpes simplex virus type 2 glycoprotein D.

Authors:  N M Mattion; P A Reilly; E Camposano; S L Wu; S J DiMichele; S T Ishizaka; S E Fantini; J C Crowley; C Weeks-Levy
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

7.  Identification of functional regions of herpes simplex virus glycoprotein gD by using linker-insertion mutagenesis.

Authors:  H Y Chiang; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

8.  Duck enteritis virus glycoprotein D and B DNA vaccines induce immune responses and immunoprotection in Pekin ducks.

Authors:  Yan Zhao; Yongsheng Cao; Lihong Cui; Bo Ma; Xiaoyu Mu; Yanwei Li; Zhihui Zhang; Dan Li; Wei Wei; Mingchun Gao; Junwei Wang
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

9.  Expression of variable viruses as herpes simplex glycoprotein D and varicella zoster gE glycoprotein using a novel plasmid based expression system in insect cell.

Authors:  A M Al-Sulaiman; P J Vallely; P E Klapper; Raid Al Baradie; Shaihana Abdulrahman Almatrrouk; Khalid K Alharbi
Journal:  Saudi J Biol Sci       Date:  2016-05-10       Impact factor: 4.219

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.